REDLAM SURGERY
62-64 REDLAM, BLACKBURN
CKD 5
The percentage of patients on the CKD register with hypertension and proteinuria who are treated with an angiotensin coverting enzyme inhibitor (ACE-I) or angiotensin receptor blocker (AEB) (unless a contraindication or side effects are recorded)
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| CKD 4 | 2007 | 100 | 135 | 74.1% | |
| CKD 4 | 2008 | 122 | 142 | 85.9% | |
| CKD 5 | 2009 | 44 | 44 | 100.0% | |
| CKD 5 | 2010 | 29 | 30 | 96.7% | |
| CKD 5 | 2011 | 31 | 35 | 88.6% | |
| CKD 5 | 2012 | 37 | 40 | 92.5% | |
| CKD 5 | 2013 | 37 | 39 | 94.9% | |
| CKD003 | 2014 | 29 | 29 | 100.0% | |
| CKD003 | 2015 | 28 | 28 | 100.0% | |
| NM84 | 2016 | 26 | 30 | 86.7% | |
| NM84 | 2018 | 17 | 24 | 70.8% | |
| NM84 | 2022 | 17 | 22 | 77.3% | |
| NM84 | 2023 | 14 | 21 | 66.7% |
